Market Overview - U.S. markets ended the week with mixed results, as major benchmarks showed modest declines while small-cap stocks outperformed, with the Russell 2000 achieving record highs [2][4] - The Dow Jones Industrial Average and S&P 500 experienced slight decreases, while the Nasdaq also slipped, indicating an uneven market rally [2][3] Sector Performance - Semiconductor and AI-related technology stocks, particularly Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC), contributed to market stability earlier in the week, with TSMC reporting a 35% increase in net profit, driven by strong AI demand [3][6] - Bank earnings from Goldman Sachs and Morgan Stanley supported trading, despite rising Treasury yields and modest increases in oil prices [3] Small-Cap Stocks - The Russell 2000's performance marked a significant outperformance streak against the S&P 500, a trend not seen since 2008, bolstered by strong economic indicators such as low initial jobless claims [4] Notable Stock Movements - Venus Concept Inc. saw its stock surge over 500% after Madryn Asset Management acquired a 91% stake, leading to increased trading volume and investor interest despite recent revenue declines [8] - J.B. Hunt Transport Services Inc. reported mixed Q4 results, with revenue of approximately $3.097 billion slightly missing expectations, while earnings per share of $1.90 exceeded forecasts [11] - Plus Therapeutics Inc. faced a stock decline after pricing a public offering to raise $15 million at a discounted price, impacting investor sentiment [12] Analyst Insights - Rocket Lab USA, Inc. received a rare downgrade from Loop Capital, citing valuation concerns and near-term execution risks, which led to a decline in its stock price [10]

Market Overview - U.S. stocks showed mixed performance, with the Dow Jones index decreasing by 0.1% to 49,398.52, while the NASDAQ rose by 0.13% to 23,559.46 and the S&P 500 increased by 0.09% to 6,950.87 [1] - European shares declined, with the eurozone's STOXX 600 falling by 0.21%, Spain's IBEX 35 Index down by 0.14%, London's FTSE 100 slipping by 0.13%, Germany's DAX decreasing by 0.36%, and France's CAC 40 down by 0.91% [7] - Asian markets mostly closed lower, with Japan's Nikkei down by 0.32%, Hong Kong's Hang Seng Index declining by 0.29%, China's Shanghai Composite falling by 0.26%, while India's BSE Sensex gained by 0.23% [8] Sector Performance - Information technology shares increased by 0.3% on Friday, while materials stocks dipped by 1% [2] Commodities - Oil prices rose by 1% to $59.78, while gold decreased by 0.2% to $4,613.60. Silver fell by 3.4% to $89.170, and copper dropped by 2.7% to $5.8310 [6] Company News - Venus Concept Inc (NASDAQ:VERO) shares surged by 376% to $6.80 following a report of Madryn Asset Management holding a 91% stake [10] - Jeffs Brands Ltd (NASDAQ:JFBR) shares increased by 196% to $1.65 after announcing a distribution agreement for its subsidiary [10] - Locafy Ltd (NASDAQ:LCFY) shares rose by 73% to $5.44 due to an expanded partnership announcement [10] - Sasol Ltd (NYSE:SSL) shares fell by 12% to $6.30 after a downgrade from JP Morgan [10] - Sigma Lithium Corp (NASDAQ:SGML) shares decreased by 10% to $12.87 amid reports of safety concerns leading to the shutdown of waste piles in Brazil [10] - Erayak Power Solution Group Inc (NASDAQ:RAYA) shares dropped by 24% to $3.00, reflecting overall market weakness in electrical equipment companies [10] Economic Indicators - U.S. industrial production increased by 0.4% month-over-month in December, matching the previous month's performance and exceeding market estimates of 0.1% [3][11] - The Federal Reserve Bank of New York's general business activity index improved to -16.1 in January from -20.0 in the prior month [11]

Market Overview - U.S. stocks experienced an upward trend, with the Nasdaq Composite increasing by over 100 points on Friday. The Dow rose by 0.13% to 49,508.69, the NASDAQ surged by 0.51% to 23,649.47, and the S&P 500 gained 0.28% to 6,963.79 [1] Company Earnings - M&T Bank reported strong fourth-quarter earnings, posting $4.72 per share, surpassing the analyst consensus estimate of $4.47 per share. The company also reported quarterly sales of $2.475 billion, slightly exceeding the analyst consensus estimate of $2.474 billion [2] Commodity Market - In commodity trading, oil prices increased by 1.1% to $59.82, while gold prices decreased by 0.6% to $4,598.10. Silver fell by 4.6% to $88.070, and copper dropped by 2.9% to $5.8170 [5] Asian Market Performance - Asian markets closed mostly lower, with Japan's Nikkei down by 0.32%, Hong Kong's Hang Seng Index declining by 0.29%, and China's Shanghai Composite falling by 0.26%. However, India's BSE Sensex saw a slight increase of 0.23% [7] Stock Movements - Venus Concept Inc saw a significant increase in shares, rising by 367% to $6.68 after Madryn Asset Management reported a 91% stake in the company. Jeffs Brands Ltd shares surged by 131% to $1.29 following a distribution agreement announcement. Locafy Ltd shares increased by 74% to $5.46 due to an expanded partnership [9] - Conversely, Callan JMB Inc shares dropped by 29% to $2.98 after signing a strategic agreement with Biostax Corp. Youlife Group Inc and Erayak Power Solution Group Inc also experienced declines of 24% to $0.96 and $3.00, respectively, amid overall market weakness [9]

Market Overview - U.S. stocks experienced an upward trend, with the Nasdaq Composite increasing by over 100 points on Friday. The Dow rose by 0.13% to 49,508.69, the NASDAQ surged by 0.51% to 23,649.47, and the S&P 500 gained 0.28% to 6,963.79 [1] Company Earnings - M&T Bank reported strong fourth-quarter earnings, posting $4.72 per share, surpassing the analyst consensus estimate of $4.47 per share. The company also reported quarterly sales of $2.475 billion, slightly exceeding the analyst consensus estimate of $2.474 billion [2] Commodity Market - In commodity trading, oil prices increased by 1.1% to $59.82, while gold prices decreased by 0.6% to $4,598.10. Silver fell by 4.6% to $88.070, and copper dropped by 2.9% to $5.8170 [5] Stock Movements - Venus Concept Inc saw a significant increase in shares, rising 367% to $6.68 after Madryn Asset Management reported a 91% stake in the company. Jeffs Brands Ltd shares surged 131% to $1.29 following a distribution agreement announcement. Locafy Ltd shares increased by 74% to $5.46 due to an expanded partnership [9] - Conversely, Callan JMB Inc shares dropped by 29% to $2.98 after signing a strategic agreement with Biostax Corp. Youlife Group Inc shares fell by 24% to $0.96, and Erayak Power Solution Group Inc shares decreased by 24% to $3.00 amid overall market weakness [9]

Core Insights - PainReform Ltd. announced a name change and is expanding into diversified healthcare and AI-driven energy platforms, resulting in a 27.4% increase in share price to $1.02 in pre-market trading [1] Gainers - Acco Group Holdings Limited saw a significant gain of 219.4%, reaching $9.40 in pre-market trading [4] - Venus Concept Inc. increased by 72.2% to $2.48 [4] - Jaguar Health, Inc. rose 41.3% to $1.08 following a licensing agreement with Woodward Specialty [4] - ImmunityBio, Inc. gained 22.8% to $4.85, with preliminary net product revenue for Anktiva projected at approximately $113 million for fiscal 2025, marking a 700% year-over-year increase [4] - OneMedNet Corporation rose 14.2% to $0.9711 after a previous decline [4] - Brand Engagement Network, Inc. increased by 13.8% to $6.50 [4] - Springview Holdings Ltd rose 13.4% to $19.75 after a substantial 657% increase on Thursday [4] - Creative Global Technology Holdings Limited gained 10.7% to $4.22 after a 52% jump on Thursday [4] - Kopin Corporation increased by 8.1% to $3.20 [4] Losers - Callan JMB Inc. fell 20.7% to $3.33 after a 275% increase on Thursday due to a strategic agreement with Biostax Corp [4] - Erayak Power Solution Group Inc. decreased by 18.3% to $3.21 after an 18% rise on Thursday [4] - TryHard Holdings Limited dropped 16.4% to $6.35 following a 76% decline on Thursday due to a joint venture announcement [4] - iOThree Limited shares dipped 15% to $2.56 [4] - NOVONIX Limited fell 14% to $1.17 [4] - Moolec Science SA tumbled 13.1% to $6.69 after an 118% increase on Thursday [4] - High Roller Technologies, Inc. declined 12.9% to $20.64 after a 25% rise on Thursday [4] - Bonk, Inc. fell 10.4% to $3.55 after a 42% increase on Thursday due to acquisition news [4] - J B Hunt Transport Services Inc fell 4.2% to $197.86, reporting mixed financial results for the fourth quarter [4] - QXO Inc dipped 3.5% to $24.14 after announcing a $750 million stock offering and preliminary fourth-quarter net sales of $2.19 billion [4]

Group 1: B Riley Financial Inc - B Riley Financial reported earnings of $4.50 per share for the second quarter, a significant improvement from a loss of $14.35 per share in the same period last year [1] - The company's sales surged to $225.302 million, up from $94.885 million year-over-year [1] - Following the earnings report, B Riley Financial shares jumped 25% to $4.65 in pre-market trading [1] Group 2: Other Stocks in Pre-Market Trading - Biodexa Pharmaceuticals PLC-ADR gained 51.4% to $7.24 in pre-market trading [4] - Venus Concept Inc surged 31.1% to $2.19 after a decline of over 10% on Monday [4] - Uniqure NV rose 14.1% to $23.30 after gaining 5% on Monday [4] - Adagio Medical Holdings Inc gained 11.7% to $0.93 after a 15% decline on Monday [4] - Sunrise New Energy Co Ltd rose 10.5% to $0.94 after dipping 11% on Monday [4] - Socket Mobile Inc surged 10.3% to $1.29 in pre-market trading [4] - Rain Enhancement Technologies Holdco Inc shares jumped 10.1% to $6.65 in pre-market trading [4] - Organogenesis Holdings Inc gained 9.3% to $5.29 after announcing a planned Type-B meeting with the FDA [4] - Nektar Therapeutics rose 7.8% to $57.50 in pre-market trading [4] Group 3: Stocks Declining in Pre-Market Trading - Radiopharm Theranostics ADR fell 39.8% to $6.40 after a significant jump of 150% on Monday [4] - Saverone 2014 Ltd – ADR tumbled 37.8% to $2.20 after gaining 18% on Monday [4] - Zynex Inc fell 36.6% to $0.42 after a decline of around 10% on Monday [4] - Immuron Ltd – ADR fell 23.8% to $0.74 after a 5% decline on Monday [4] - iRobot Corp fell 23.2% to $0.90 after dipping 73% on Monday due to filing for Chapter 11 bankruptcy [4] - Envirotech Vehicles Inc dipped 17% to $0.93 in pre-market trading [4] - Aldeyra Therapeutics Inc declined 15.7% to $3.36 following a PDUFA extension for Reproxalap NDA [4] - Ascent Solar Technologies, Inc. dipped 15.1% to $3.54 after a 34% jump on Monday [4] - Lightwave Logic Inc dipped 14.5% to $3.22 after announcing a $35 million public offering [4] - Fractyl Health Inc fell 10.4% to $2.00 in pre-market trading [4]

Core Insights - Venus Concept Inc. has received FDA 510(k) clearance for its new product, Venus NOVA, marking a significant milestone in the company's R&D strategy [1][3] - Venus NOVA is designed to provide a comprehensive solution for non-invasive body, face, and skin treatments, integrating multiple advanced technologies [2][3] Product Features - Venus NOVA incorporates Adaptive Electrical Muscle Stimulation (EMS), Multi-Polar Radio Frequency (RF) combined with Pulsed Electromagnetic Fields (PEMF), and Advanced VariPulse™ technology [2][4] - The platform aims to enhance body contouring, muscle conditioning, skin treatments, and reduce wrinkles and cellulite [2] Strategic Initiatives - The launch of Venus NOVA aligns with the company's turnaround strategy initiated in 2023 and the Venus AI strategic initiative, focusing on innovation and customer partnerships [3] - The product is expected to support the growing demand for aesthetic treatments, particularly for patients using GLP-1 medications, with an anticipated increase to over 32 million users globally by 2030 [3] Market Positioning - Venus NOVA is positioned to penetrate the multi-billion-dollar body and skin market, contributing to the company's long-term growth profile [3] - The product will be available in the U.S. starting December 2025, with global rollouts planned for 2026 and beyond [6] Support Programs - The Venus Jumpstart Program will provide a 30-day roadmap for advanced clinical education and marketing enablement to ensure successful integration of Venus NOVA into existing practices [4][5]

Core Viewpoint - Venus Concept Inc. reported financial results for Q4 and FY2024, highlighting ongoing industry challenges and a focus on cost management and strategic growth initiatives [3]. Financial Results Summary Fourth Quarter 2024 - Total revenue decreased by 13% year-over-year to $15.8 million, with U.S. revenue down 13% to $10.3 million and international revenue down 13% to $5.5 million [4][6]. - Revenue from Venus Prime/Subscription systems fell by 58.2%, while products-systems revenue increased by 15.4% [4][6]. - Gross profit decreased by 10% to $10.9 million, with a gross margin of 69.1% [7]. - Operating expenses declined by 11% to $17.6 million, driven by reductions in general and administrative, selling and marketing, and research and development expenses [8]. - The operating loss improved to $6.7 million from $7.6 million year-over-year [9]. - Net loss attributable to stockholders was $8.0 million, or $11.23 per share, compared to a net loss of $11.1 million, or $20.14 per share in the prior year [10]. Fiscal Year 2024 - Total revenue for FY2024 decreased by 15% to $64.8 million, with U.S. revenue down 12% to $38.2 million and international revenue down 19% to $26.7 million [12][14]. - The company achieved a significant reduction in outstanding debt from $74.9 million to $39.7 million, a 47% decrease year-over-year [5]. - Operating loss for FY2024 was $27.2 million, compared to $28.3 million in FY2023 [14]. - Net loss attributable to stockholders was $47.0 million, or $71.17 per share, compared to a net loss of $37.1 million, or $68.11 per share in the previous year [14]. Strategic Developments - The company is focused on reducing cash burn through disciplined cost management while making targeted investments for growth [3]. - Management structure changes were announced to enhance responsiveness and decisiveness in strategic planning [3]. - The company expanded its international distributor network, including partnerships in Taiwan, Colombia, and India [5]. Cash Flow and Financial Position - Cash used in operations in 2024 was $11.1 million, down 14% year-over-year [5]. - As of December 31, 2024, cash and cash equivalents were $4.3 million, down from $5.4 million a year earlier [11]. - The company amended its Bridge Loan Agreement with Madryn to create an additional $10.0 million financing capacity [5].

Financial Results Announcement - Venus Concept Inc. will release its fourth quarter and fiscal year 2024 financial results before the market opens on March 31, 2025 [1] - A conference call will be held at 8:00 a.m. Eastern Time on the same day to discuss the results, including a question and answer session [2] Participation Details - Participants can join the conference call by dialing 877-407-2991 (or 201-389-0925 for international callers) and using access code 13751985 [2] - A live webcast will be available on the investor relations section of the Company's website [2] Replay Information - A replay of the call will be accessible for two weeks at 877-660-6853 (or 201-612-7415 for international callers) with the same access code [3] - The webcast will also be archived on the Company's investor relations website [3] Company Overview - Venus Concept is a global leader in medical aesthetic technology, offering a wide range of minimally invasive and non-invasive products [4] - The Company operates in over 60 countries and has 12 direct markets, with a diverse product portfolio including various aesthetic device platforms and hair restoration systems [4] - Key investors backing Venus Concept include EW Healthcare Partners, HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations [4]

Core Viewpoint - Venus Concept Inc. announced a 1-for-11 reverse stock split to increase the bid price of its common stock and regain compliance with Nasdaq Capital Market listing requirements [1][3]. Company Actions - The reverse stock split will be effective at 5:00 p.m. EST on March 3, 2025, with trading on a split-adjusted basis starting on March 4, 2025 [1]. - The stockholders approved the reverse stock split at a special meeting on February 14, 2025, with a ratio range from 1-for-5 to 1-for-16 [2]. Stock Adjustments - Every 11 shares of common stock will be reclassified into one new share, with adjustments made to the exercise price and number of shares for outstanding warrants and convertible securities [3]. - The reverse stock split will not affect the number of authorized shares or the par value of the common stock [4]. Fractional Shares - No fractional shares will be issued; stockholders entitled to fractional shares will receive an additional fraction to round up to the next whole share [5]. Exchange Agent - Computershare Inc. has been appointed as the exchange agent for the reverse stock split, and stockholders will not need to take further action for their positions to be adjusted [6]. Company Overview - Venus Concept is a global leader in medical aesthetic technology, offering a broad product portfolio in over 60 countries, including minimally invasive and non-invasive technologies [10].